Cabaletta Bio Inc
CABA
NASDAQ
Biotechnology
$2.75
USD
+0.04 (+1.48%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $442.69M
Volume 2.3M
About Cabaletta Bio Inc
The company is headquartered in Philadelphia, Pennsylvania and currently employs 154 full-time employees. The company went IPO on 2019-10-25.
CEO
Dr. Steven Nichtberger
HQ
PHILADELPHIA, PENNSYLVANIA, US
Founded
2019
Employees
154
Key Metrics
2 metrics our research team weighs before forming a view on CABA.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
ROE (TTM)
-169.8%
-65.5 pp
Free Cash Flow (TTM)
$-143.28M
—
Financial Snapshot
Revenue
$0
— YoY
Gross Margin
—
— YoY
Net Income
$-175.43M
-38.4%
YoY
Operating Cash Flow
$-142.84M
-50.3%
YoY
Key Statistics
Open
$2.68
Previous Close
$2.71
Day Range
$2.64 - $2.77
52 Week Range
$1.40 - $4.23
Volume
2.3M
Average Volume (10 Days)
3.3M
Dividend Yield
—
Valuation Measurement
Market Cap
$442.69M
P/E Ratio (TTM)
—
Price / Book
4.29
Financial Highlights
Return on Assets
-118.4%
Return on Equity
-169.8%
Revenue (TTM)
$0
Net Income (TTM)
$-175.43M
Diluted EPS (TTM)
-$1.96
Total Cash (MRQ)
$116.64M
Levered FCF (TTM)
$-143.28M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Similar Stocks
RZLT
Rezolute Inc
$4.60
▲ 0.0%
QTTB
Q32 Bio Inc
$15.15
▼ -1.4%
FENC
Fennec Pharmaceuticals Inc
$11.72
▼ -2.8%
PRLD
Prelude Therapeutics Inc
$5.55
▲ +3.5%
EDIT
Editas Medicine Inc
$2.82
▲ +0.4%
LRMR
Larimar Therapeutics Inc
$4.36
▲ +2.1%
BNTC
Benitec Biopharma Inc
$12.56
▲ 0.0%
PBYI
Puma Biotechnology Inc
$8.83
▲ +1.4%
CMPX
Compass Therapeutics Inc.
$2.25
▼ -0.4%
Earnings Calendar
Next Earnings
Estimated Q3 Release
Nov 09
Est. EPS
Adjusted consensus estimate
-$0.33